Analyzing the Future Landscape: Cell & Gene Therapy Drug Delivery Devices Market By 2028, With a Striking CAGR of 14% – MarkNtel Advisors

How big is the Global Cell & Gene Therapy Drug Delivery Devices market?

According to MarkNtel Advisors study, The Global Cell & Gene Therapy Drug Delivery Devices Market size is projected to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28.

Get Your Hands On to the Free Sample Report (2024-30) –

Key Drivers

  • The factors that are projected to drive the market in the coming years include the following:
  • Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
  • Mounting prevalence of genetic disorders & chronic diseases
  • An increasing number of FDA approvals for cell & gene therapies & their clinical trials

Leading Companies in the Global Cell & Gene Therapy Drug Delivery Devices market:

  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Becton, Dickinson and Company
  • Bluebird bio Inc.
  • Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
  • Dendreon Pharmaceuticals LLC
  • Helixmith Co. Ltd (ViroMed Co., Ltd)
  • Human Stem Cells Institute
  • Kite Pharma Inc.
  • Kolon TissueGene, Inc.
  • Novartis AG
  • Orchard Therapeutics plc.
  • Pfizer Inc.
  • Renova Therapeutics
  • Spark Therapeutics Inc.
  • uniQure N.V.
  • Vericel Corporation

Explore Full Market Research Report –

Global Cell & Gene Therapy Drug Delivery Devices Market Segmentation:

By Product Type

  • Sub-retinal Injection Cannula
  • Extension Tube
  • Intravenous Catheter
  • Sterile Insulin Syringe
  • Size 1.0 ML, 31-Gauge Needle
  • Size 0.5 ML, 22-Gauge Needle
  • Pre-Filled Syringe
  • Size 1.0 ML, 22-26 Gauge Needle
  • Size 4.0 ML, 22-26 Gauge Needle
  • Infusion Bags
  • Infusion Bags (Size 10 ML to 50 ML)
  • Infusion Bags (Size 68 ML)
  • Infusion Bags (Size 60 ML)
  • Infusion Bags (Size Up to 65 ML)

By Technology

  • Microchip Technology
  • Nano-Technology
  • Lipid Nanoparticles

By Commercialized Drugs

  • Luxturna
  • Kymriah
  • Yescarta
  • Zolgensma
  • Provenge
  • Strimvelis

Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2021.

By End-User

  • Pharmaceuticals & Biotechnology Company
  • Academic & Research Institute
  • Hospitals & Clinics

Regional/ Countries Insight:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Of all the regions, North America attained more than 50% of the revenue share and is anticipated to prevail the same trend in the forecast period.

Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.

To Get Customized Report, Sent Your Enquiry Here –

About MarkNtel Advisors:

MarkNtel Advisors is a leading consulting, data analytics, and market research company that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Media Inquiries:

please contact: Phone: +1 628 895 8081, +91 120 4278433


Corporate Office: Office No.106, H-160, Sector 63, Noida, Uttar Pradesh – 201301, India